Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in c57bl/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet

HIGHLIGHTS

• who: Suresh R. Giri from the Department of Pharmacology and Toxicology, Zydus Research Centre, Sarkheju2011Bavla NHNo A, Moraiya, Ahmedabad, Gujarat, India Tel Aviv University, Yehuda HaMaccabi, floor, Tel Aviv, Israel have published the article: Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet, in the Journal: (JOURNAL)
• what: In line with these observations, the authors report here that saroglitazar could prevent NASH development and the progression to liver tumorigenesis. The model chosen for this study has been validated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.